alanine has been researched along with Recrudescence in 28 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was done to elucidate whether rebamipide during the initial period of acetic acid-induced gastric ulcer affected healing and future ulcer relapse." | 7.69 | Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. ( Arakawa, T; Fukuda, T; Kobayashi, K; Watanabe, T; Yamasaki, K, 1995) |
| "Rabacfosadine is a generally well tolerated, effective chemotherapy option for dogs with relapsed B-cell lymphoma." | 5.48 | Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses. ( Burgess, KE; Clifford, CA; Fan, TM; Morges, MA; Phillips, B; Saba, CF; Thamm, DH; Vail, DM; Vickery, KR; Wright, ZM, 2018) |
| "This retrospective study included 289 chronic hepatitis B (CHB) patients without cirrhosis who received entecavir (n = 93), TDF (n = 103), or TAF (n = 86) retreatment for at least 12 months after entecavir or TDF cessation." | 4.31 | Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation. ( Chang, KC; Chen, CH; Chiu, SM; Hu, TH; Hung, CH; Lu, SN; Wang, JH, 2023) |
| "This study was done to elucidate whether rebamipide during the initial period of acetic acid-induced gastric ulcer affected healing and future ulcer relapse." | 3.69 | Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. ( Arakawa, T; Fukuda, T; Kobayashi, K; Watanabe, T; Yamasaki, K, 1995) |
| "However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations." | 2.72 | COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). ( Baruchel, A; Bertrand, Y; Boissel, N; Brethon, B; Ducassou, S; Gandemer, V; Halfon-Domenech, C; Leblanc, T; Leverger, G; Michel, G; Petit, A; Ray-Lunven, AF; Rohrlich, PS; Rouger-Gaudichon, J; Schneider, P; Sirvent, N; Strullu, M, 2021) |
| "Oral aphthae count and pain scores were recorded daily in a diary by the patients themselves." | 2.71 | Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study. ( Hirohata, S; Inaba, G; Kogure, M; Matsuda, T; Miyanaga, Y; Mizushima, Y; Nakamura, S; Ohno, S; Tanaka, S; Ujihara, H, 2003) |
| "The ulcer recurrence rate was significantly lower in group OA and group OR than in group O." | 2.69 | Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status. ( Ando, K; Arakawa, T; Fujiwara, Y; Fukuda, T; Higuchi, K; Kobayashi, K; Kuroki, T; Nebiki, H; Takaishi, O; Uchida, T; Yamasaki, K, 1998) |
| "The optimal treatment for chronic coronavirus disease 2019 (COVID-19) is unknown." | 1.72 | Treatment of chronic or relapsing COVID-19 in immunodeficiency. ( AbdulKhaliq, I; Baxendale, H; Bermingham, W; Brown, LK; Brown, M; Buckland, M; Goodman, A; Hunter, M; Jarvis, H; Jenkins, M; Jolles, S; Karanam, S; Khan, S; Lowe, DM; Moran, E; Patel, A; Richter, A; Robbins, A; Savic, S; Shields, A; Simpson, T; Underwood, J, 2022) |
| "Rabacfosadine is a generally well tolerated, effective chemotherapy option for dogs with relapsed B-cell lymphoma." | 1.48 | Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses. ( Burgess, KE; Clifford, CA; Fan, TM; Morges, MA; Phillips, B; Saba, CF; Thamm, DH; Vail, DM; Vickery, KR; Wright, ZM, 2018) |
| "Mucosal inflammation is a crucial factor for the recurrence of peptic ulcer." | 1.33 | Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils. ( Osaka, T; Sakurai, K; Yamasaki, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 7 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, LK | 1 |
| Moran, E | 1 |
| Goodman, A | 1 |
| Baxendale, H | 1 |
| Bermingham, W | 1 |
| Buckland, M | 1 |
| AbdulKhaliq, I | 1 |
| Jarvis, H | 1 |
| Hunter, M | 1 |
| Karanam, S | 1 |
| Patel, A | 1 |
| Jenkins, M | 1 |
| Robbins, A | 1 |
| Khan, S | 1 |
| Simpson, T | 1 |
| Jolles, S | 1 |
| Underwood, J | 1 |
| Savic, S | 1 |
| Richter, A | 1 |
| Shields, A | 1 |
| Brown, M | 1 |
| Lowe, DM | 1 |
| Rüfenacht, S | 1 |
| Gantenbein, P | 1 |
| Boggian, K | 1 |
| Flury, D | 1 |
| Kern, L | 1 |
| Dollenmaier, G | 1 |
| Kohler, P | 1 |
| Albrich, WC | 1 |
| Chiu, SM | 1 |
| Chang, KC | 1 |
| Hu, TH | 2 |
| Hung, CH | 2 |
| Wang, JH | 2 |
| Lu, SN | 2 |
| Chen, CH | 2 |
| Jeng, WJ | 1 |
| Liu, YC | 1 |
| Chien, RN | 1 |
| Rouger-Gaudichon, J | 1 |
| Bertrand, Y | 1 |
| Boissel, N | 1 |
| Brethon, B | 1 |
| Ducassou, S | 1 |
| Gandemer, V | 1 |
| Halfon-Domenech, C | 1 |
| Leblanc, T | 1 |
| Leverger, G | 1 |
| Michel, G | 1 |
| Petit, A | 1 |
| Ray-Lunven, AF | 1 |
| Rohrlich, PS | 1 |
| Schneider, P | 1 |
| Sirvent, N | 1 |
| Strullu, M | 1 |
| Baruchel, A | 1 |
| Nizet, A | 1 |
| Foguenne, J | 1 |
| Gothot, A | 1 |
| Tassin, F | 1 |
| Keutgens, A | 1 |
| Palomba, E | 1 |
| Carrabba, M | 1 |
| Zuglian, G | 1 |
| Alagna, L | 1 |
| Saltini, P | 1 |
| Fortina, V | 1 |
| Hu, C | 1 |
| Bandera, A | 1 |
| Fabio, G | 1 |
| Gori, A | 1 |
| Muscatello, A | 1 |
| Saba, CF | 1 |
| Vickery, KR | 1 |
| Clifford, CA | 1 |
| Burgess, KE | 1 |
| Phillips, B | 1 |
| Vail, DM | 1 |
| Wright, ZM | 1 |
| Morges, MA | 1 |
| Fan, TM | 1 |
| Thamm, DH | 1 |
| Mocking, RJ | 1 |
| Lok, A | 1 |
| Assies, J | 1 |
| Koeter, MW | 1 |
| Visser, I | 1 |
| Ruhé, HG | 1 |
| Bockting, CL | 1 |
| Schene, AH | 1 |
| Jacobs, M | 1 |
| Rodger, A | 1 |
| Bell, DJ | 1 |
| Bhagani, S | 1 |
| Cropley, I | 1 |
| Filipe, A | 1 |
| Gifford, RJ | 1 |
| Hopkins, S | 1 |
| Hughes, J | 1 |
| Jabeen, F | 1 |
| Johannessen, I | 1 |
| Karageorgopoulos, D | 1 |
| Lackenby, A | 1 |
| Lester, R | 1 |
| Liu, RS | 1 |
| MacConnachie, A | 1 |
| Mahungu, T | 1 |
| Martin, D | 1 |
| Marshall, N | 1 |
| Mepham, S | 1 |
| Orton, R | 1 |
| Palmarini, M | 1 |
| Patel, M | 1 |
| Perry, C | 1 |
| Peters, SE | 1 |
| Porter, D | 1 |
| Ritchie, D | 1 |
| Ritchie, ND | 1 |
| Seaton, RA | 1 |
| Sreenu, VB | 1 |
| Templeton, K | 1 |
| Warren, S | 1 |
| Wilkie, GS | 1 |
| Zambon, M | 1 |
| Gopal, R | 1 |
| Thomson, EC | 1 |
| Djordjevic, V | 1 |
| Mitic, G | 1 |
| Pruner, I | 1 |
| Kovac, M | 1 |
| Radojkovic, D | 1 |
| Adachi, K | 1 |
| Furuta, K | 1 |
| Miwa, H | 1 |
| Oshima, T | 1 |
| Miki, M | 1 |
| Komazawa, Y | 1 |
| Iwakiri, K | 1 |
| Furuta, T | 1 |
| Koike, T | 1 |
| Shimatani, T | 1 |
| Kinoshita, Y | 1 |
| Matsuda, T | 1 |
| Ohno, S | 1 |
| Hirohata, S | 1 |
| Miyanaga, Y | 1 |
| Ujihara, H | 1 |
| Inaba, G | 1 |
| Nakamura, S | 1 |
| Tanaka, S | 1 |
| Kogure, M | 1 |
| Mizushima, Y | 1 |
| Murata, T | 1 |
| Masunaga, T | 1 |
| Ishiko, A | 1 |
| Shimizu, H | 1 |
| Nishikawa, T | 1 |
| Sakurai, K | 1 |
| Osaka, T | 1 |
| Yamasaki, K | 4 |
| Fujiwara, Y | 2 |
| Higuchi, K | 2 |
| Tominaga, K | 1 |
| Watanabe, T | 2 |
| Arakawa, T | 4 |
| Scirica, BM | 1 |
| Morrow, DA | 1 |
| Cannon, CP | 3 |
| de Lemos, JA | 1 |
| Murphy, S | 1 |
| Sabatine, MS | 1 |
| Wiviott, SD | 1 |
| Rifai, N | 1 |
| McCabe, CH | 1 |
| Braunwald, E | 1 |
| Furue, T | 1 |
| Hattori, M | 1 |
| Tsukaguchi, H | 1 |
| Kitamura, A | 1 |
| Oomori, T | 1 |
| Ogino, D | 1 |
| Nakakura, H | 1 |
| Ashida, A | 1 |
| Miura, K | 1 |
| Hisano, M | 1 |
| Takahashi, K | 1 |
| Chikamoto, H | 1 |
| Akioka, Y | 1 |
| Sakano, T | 1 |
| Shido, F | 1 |
| Morimoto, K | 1 |
| Fukuda, T | 2 |
| Kobayashi, K | 3 |
| Yoshikawa, T | 1 |
| Tarnawski, A | 1 |
| Nebiki, H | 1 |
| Uchida, T | 1 |
| Ando, K | 1 |
| Takaishi, O | 1 |
| Kuroki, T | 1 |
| Holmes, MB | 1 |
| Sobel, BE | 1 |
| Schneider, DJ | 1 |
| Shields, DC | 1 |
| Fitzgerald, AP | 1 |
| O'Neill, PA | 1 |
| Muckian, C | 1 |
| Kenny, D | 1 |
| Moran, B | 1 |
| Byrne, CE | 1 |
| Fitzgerald, DJ | 1 |
| White, D | 1 |
| Abraham, G | 1 |
| Carter, C | 1 |
| Kakkar, VV | 1 |
| Cooper, DN | 1 |
| Ireland, H | 1 |
| Lane, DA | 1 |
| Thompson, E | 1 |
| Walker, ID | 1 |
| Blench, I | 1 |
| Morris, HR | 1 |
| Freyssinet, JM | 1 |
| Grunebaum, L | 1 |
| Olds, R | 1 |
| Thein, SL | 1 |
| Shiraki, M | 1 |
| Ishiyama, H | 1 |
| Kanbe, T | 1 |
| Yabuuchi, Y | 1 |
| Asada, S | 1 |
| Hirata, I | 1 |
| Ooshiba, S | 1 |
| Corbeel, L | 1 |
| Beckels, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characterizing SARS-CoV-2 Persistence in Host Reservoirs, Post-viral Sequelae, and Associations With Host and Viral Determinants in a Cohort of Convalescent COVID-19 Cases[NCT04448145] | 325 participants (Anticipated) | Observational | 2020-03-26 | Recruiting | |||
| Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease: A Randomized Clinical Trial[NCT06084624] | Phase 1/Phase 2 | 40 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for alanine and Recrudescence
| Article | Year |
|---|---|
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).
Topics: Adenosine Monophosphate; Adolescent; Adrenal Cortex Hormones; Alanine; Antiviral Agents; Cancer Care | 2021 |
[Quality of ulcer healing and rebamipide].
Topics: Alanine; Amoxicillin; Animals; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination | 2005 |
Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
Topics: Alanine; Animals; Anti-Ulcer Agents; Clinical Trials as Topic; Disease Models, Animal; Gastric Mucos | 1998 |
7 trials available for alanine and Recrudescence
| Article | Year |
|---|---|
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; COVID-19; COVID-19 Drug | 2022 |
A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alanine; Dose-Response Rela | 2012 |
Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Behcet Syndrome; Double-Blind Method; Drug Therapy, Combina | 2003 |
Clinical application of C-reactive protein across the spectrum of acute coronary syndromes.
Topics: Acute Disease; Aged; Alanine; Angina Pectoris; Angina, Unstable; C-Reactive Protein; Coronary Diseas | 2007 |
Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Topics: Aged; Alanine; Anti-Ulcer Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 1998 |
Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction.
Topics: Acute Disease; Administration, Oral; Alanine; Blood Platelets; Coronary Thrombosis; Fibrinogen; Huma | 2000 |
The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.
Topics: Alanine; Coronary Disease; Genotype; Glycoproteins; Hemorrhage; Humans; Myocardial Infarction; Myoca | 2002 |
18 other studies available for alanine and Recrudescence
| Article | Year |
|---|---|
Treatment of chronic or relapsing COVID-19 in immunodeficiency.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antibodies, Monoclonal; Antiviral | 2022 |
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation.
Topics: Adenine; Alanine; Antiviral Agents; DNA, Viral; Hepatitis B, Chronic; Humans; Recurrence; Retreatmen | 2023 |
HBV relapse rates in patients who discontinue tenofovir disoproxil fumarate with or without switching to tenofovir alafenamide.
Topics: Adenine; Alanine; Hepatitis B virus; Humans; Recurrence; Tenofovir | 2023 |
Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report.
Topics: Adenosine Monophosphate; Alanine; Allografts; Antiviral Agents; Bone Marrow; Chromosomes, Human, Pai | 2021 |
Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia.
Topics: Adenosine Monophosphate; Adult; Agammaglobulinemia; Alanine; Antibodies, Neutralizing; Antibodies, V | 2021 |
Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses.
Topics: Alanine; Animals; Antineoplastic Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Lymph | 2018 |
Ala54Thr fatty acid-binding protein 2 (FABP2) polymorphism in recurrent depression: associations with fatty acid concentrations and waist circumference.
Topics: Adult; Alanine; Arachidonic Acid; Depressive Disorder, Major; Eicosanoic Acids; Erythrocytes; Fatty | 2013 |
Late Ebola virus relapse causing meningoencephalitis: a case report.
Topics: Acute Disease; Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Cranial Nerve Diseases; Di | 2016 |
Are thrombophilia more multifactorial than we thought: report of mosaicism for FII G20210A and novel FII T20061C gene variants.
Topics: Alanine; Biomarkers; Cysteine; Female; Genotype; Glycine; Humans; Hypertension, Pulmonary; Middle Ag | 2012 |
Differences in recurrent COL7A1 mutations in dystrophic epidermolysis bullosa: ethnic-specific and worldwide recurrent mutations.
Topics: Alanine; Arginine; Asian People; Collagen Type VII; Cysteine; Epidermolysis Bullosa Dystrophica; Gen | 2004 |
Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.
Topics: Acetic Acid; Alanine; Animals; Anti-Ulcer Agents; Free Radicals; Gastric Mucosa; Glutathione Peroxid | 2005 |
Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.
Topics: Alanine; Child; Child, Preschool; DNA Mutational Analysis; Female; Glomerulosclerosis, Focal Segment | 2008 |
Amino acid transport in human tonsillar lymphocytes with regard to patient's age and tonsillar diseases.
Topics: Adult; Age Factors; Alanine; Amino Acids; Arthritis, Rheumatoid; B-Lymphocytes; Biological Transport | 1984 |
Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine.
Topics: Acetates; Acetic Acid; Alanine; Animals; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; M | 1995 |
A novel missense mutation in the antithrombin III gene (Ala387-->Val) causing recurrent venous thrombosis.
Topics: Adult; Alanine; Antithrombin III; Antithrombin III Deficiency; Humans; Mutation; Polymerase Chain Re | 1992 |
Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
Topics: Adult; Alanine; Antithrombin III; Electrophoresis, Polyacrylamide Gel; Female; Humans; Male; Middle | 1991 |
[Healing promoting effect of proamipide, a novel drug that increases gastric defense mechanisms, on acetic acid-induced gastric ulcers in the rat].
Topics: Acetates; Alanine; Animals; Anti-Ulcer Agents; Fibrosis; Gastric Mucosa; Granulation Tissue; Male; Q | 1988 |
Recurrent attacks of ketoacidosis with hyperlacticacidaemia, hyperpyruvicacidaemia and hyperalaninaemia.
Topics: Acidosis; Alanine; Biopsy; Child; Female; Glucose Tolerance Test; Humans; Ketoglutaric Acids; Lactat | 1973 |